Related Experiment Videos
Histamine-induced villous damage in the rat duodenum
H Tanaka1, K Takeuchi, S Okabe
1Department of Applied Pharmacology, Kyoto Pharmaceutical University, Japan.
Japanese Journal of Pharmacology
|October 1, 1989
Summary
Histamine administration causes dose-dependent duodenal villous damage in rats, characterized by epithelial cell exfoliation. This damage heals within 8 hours and can be mitigated by acid-reducing agents.
Area of Science:
- Gastroenterology
- Pharmacology
- Histology
Background:
- Histamine is a known mediator of gastric acid secretion.
- The effects of histamine on duodenal mucosa integrity require further elucidation.
Purpose of the Study:
- To investigate the impact of histamine administration on duodenal villous morphology in rats.
- To determine the time course of histamine-induced duodenal damage and healing.
- To assess the protective effects of acid-reducing agents against histamine-induced duodenal injury.
Main Methods:
- Rats were administered varying doses of histamine subcutaneously after a 24-hour fast.
- Duodenal tissues were examined histologically at different time points post-administration.
- Gastric acid secretion and intraduodenal pH were monitored.
- The effects of oral sodium bicarbonate and subcutaneous cimetidine, omeprazole, and NC-1300 were evaluated.
Main Results:
- Histamine induced dose-dependent villous damage in the proximal duodenum, with peak epithelial exfoliation observed at 0.5 hours.
- Duodenal damage showed a trend towards healing, with near-complete recovery by 8 hours.
- Histamine significantly increased gastric acid secretion and decreased intraduodenal pH for 1 hour.
- Pretreatment with sodium bicarbonate, cimetidine, omeprazole, or NC-1300 significantly inhibited histamine-induced duodenal damage.
Conclusions:
- Histamine induces acute, reversible duodenal villous damage primarily through the stimulation of gastric acid secretion.
- The findings highlight the role of gastric acid in mediating histamine-induced duodenal injury.
- Acid-reducing agents demonstrate efficacy in preventing histamine-induced duodenal damage.